How to Get AndroGel in New York

What AndroGel Is and Why New York Patients Seek It

AndroGel delivers testosterone transdermally in two strengths: 1% (delivering 25 mg or 50 mg per dose) and 1.62% (delivering 20.25 mg or 40.5 mg per dose). The FDA approved the original 1% formulation in 2000 and the 1.62% formulation in 2011, both specifically for adult male hypogonadism caused by primary or hypogonadotropic conditions. 1

Hypogonadism affects roughly 2 to 6 percent of adult men across the general population, with prevalence rising sharply after age 45. 2 New York's population of approximately 20 million means hundreds of thousands of men may qualify for treatment. Despite that scale, many men in the state still lack access because primary care physicians frequently refer testosterone management to specialists, creating wait times of 4 to 12 weeks at major academic centers.

Telehealth has changed that calculus. New York amended its telehealth statutes in 2019 to permit prescribing of Schedule III controlled substances via synchronous audio-visual encounters, subject to DEA registration requirements. A licensed New York provider who meets DEA telemedicine standards may write a Schedule III controlled substance prescription without a prior in-person visit, provided the encounter includes live two-way video. 3

The Diagnostic Criteria You Must Meet

AndroGel is approved for symptomatic hypogonadism, not for low-normal testosterone in asymptomatic men. Meeting the clinical threshold matters both for safety and for insurance coverage.

The Endocrine Society's 2018 Clinical Practice Guideline defines biochemical hypogonadism as a consistently low serum total testosterone concentration confirmed on two separate morning blood draws. 4 The diagnostic cutoff is generally below 300 ng/dL, though some guidelines place it at below 264 ng/dL. Symptoms must also be present, including fatigue, reduced libido, erectile dysfunction, loss of muscle mass, depressed mood, or some combination of these.

Blood should be drawn between 7 a.m. and 10 a.m., because testosterone secretion follows a circadian rhythm that peaks in early morning. An afternoon draw can underestimate true levels by 20 to 30 percent. 5

The T-Trials (N=788 men aged 65 and older with total testosterone below 275 ng/dL) demonstrated that testosterone treatment significantly improved sexual function, physical capacity, and bone mineral density versus placebo over 12 months. 6 That evidence base supports treatment in appropriately selected patients and forms the backbone of guideline-based prescribing in New York and nationwide.

Secondary causes must be ruled out. Your provider will order luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to distinguish primary hypogonadism (high LH/FSH, testicular failure) from secondary hypogonadism (low or normal LH/FSH, pituitary or hypothalamic origin). A prolactin level screens for prolactinoma. Sex hormone-binding globulin (SHBG) helps interpret free testosterone when total testosterone sits near the borderline.

Required Labs Before a Prescription Is Written

New York providers prescribing AndroGel follow a standard pre-treatment panel. Ordering this before your appointment cuts the overall timeline by 3 to 5 days.

The minimum panel includes:

Hormone panel. Total testosterone (two separate morning draws at least 24 hours apart), free testosterone or calculated free testosterone, LH, FSH, prolactin, and SHBG.

Safety baseline. Complete blood count (CBC) with hematocrit, PSA (for men over 40), comprehensive metabolic panel, and lipid panel. Testosterone therapy raises hematocrit; a pre-treatment value above 50 percent is a relative contraindication. 7

Optional but frequently ordered. Thyroid-stimulating hormone (TSH) and hemoglobin A1c, because hypothyroidism and type 2 diabetes both independently suppress testosterone and may need treatment before gel therapy begins.

Quest Diagnostics and LabCorp both operate dozens of draw sites across New York City, Long Island, Westchester, and upstate locations. Most telehealth TRT platforms generate a requisition form you can use at either chain without an additional office visit. Results typically return within 24 to 48 hours.

Who Can Prescribe AndroGel in New York

New York law permits four practitioner types to prescribe Schedule III controlled substances, including testosterone gel:

Medical doctors (MD) and doctors of osteopathic medicine (DO). No collaborative practice agreement is required. An MD or DO with a valid DEA registration may prescribe AndroGel independently. 8

Nurse practitioners (NP). New York transitioned to full practice authority for NPs in 2023 after a three-year collaborative practice period. NPs with full practice authority and a DEA Schedule III registration may independently prescribe testosterone. 9

Physician assistants (PA). PAs in New York must have a supervising physician and a collaborative practice agreement that explicitly authorizes Schedule III prescribing. A PA alone cannot prescribe testosterone without that agreement on file.

Specialty focus. Urologists and endocrinologists manage the majority of TRT cases at academic medical centers. Men's health clinics and telehealth platforms typically staff board-certified internists or family medicine physicians with specific hormone therapy training.

How to Get AndroGel Through a New York Telehealth Provider

The telehealth pathway is the fastest route for most patients and does not require leaving home for an initial consultation.

Step 1. Choose a licensed New York telehealth provider. Confirm that the platform holds a valid New York State telehealth certificate and that its prescribers carry a DEA registration for Schedule III substances in New York.

Step 2. Complete an intake questionnaire covering symptom severity, medical history, current medications, and prior hormone testing.

Step 3. Order labs. The platform generates a blood draw order. Complete the draw at a Quest or LabCorp site near you. Most platforms require results before scheduling the video visit, though some allow a provisional intake call.

Step 4. Attend a synchronous audio-visual appointment. New York requires live two-way video for Schedule III controlled substance prescribing. Phone-only encounters do not satisfy this requirement.

Step 5. Receive the prescription electronically. New York accepts e-prescribing for Schedule III substances under the Electronic Prescribing for Controlled Substances (EPCS) system. The prescription routes directly to your preferred pharmacy or to the platform's mail-order partner.

Step 6. Pick up or receive AndroGel. Retail pharmacies fill same-day. Mail-order pharmacies typically deliver within 2 to 5 business days.

New York Pharmacy Options for AndroGel

Retail Chain Pharmacies

CVS, Walgreens, Rite Aid, and Duane Reade locations across New York carry brand-name AndroGel and, where available, generic testosterone gel. Brand-name AndroGel 1.62% carries a cash price of roughly $400 to $600 per 30-day supply. Generic testosterone 1.62% gel from Perrigo or Actavis may cost $150 to $280 cash.

GoodRx coupons can reduce generic testosterone gel to $40 to $90 at participating New York pharmacies, though coupon pricing cannot be combined with insurance. 10

Mail-Order Pharmacies

OptumRx, Express Scripts, CVS Caremark, and Amazon Pharmacy all service New York patients. Mail-order pricing for a 90-day supply is typically 10 to 15 percent lower per unit than retail 30-day fills under commercial insurance.

503A Compounding Pharmacies in New York

New York State-licensed 503A compounding pharmacies may prepare patient-specific testosterone gel formulations when commercially available AndroGel is clinically inappropriate or cost-prohibitive. These pharmacies operate under oversight by the New York State Board of Pharmacy and must comply with United States Pharmacopeia (USP) Chapter 795 standards for non-sterile compounding. 11

Compounded testosterone gel is not FDA-approved, which means it cannot carry the same bioequivalence guarantee as the branded product. The Endocrine Society notes that "compounded testosterone preparations should be used only when FDA-approved products are unavailable or when a patient has a documented intolerance to excipients in commercial formulations." 4

Cash pricing for compounded testosterone gel ranges from $30 to $80 per month depending on concentration (typically 1%, 2%, or 5%) and volume. Most 503A pharmacies ship within New York State with a valid prescription; interstate shipping rules vary and require verification with the pharmacy directly.

Insurance Coverage and Prior Authorization in New York

Commercial insurance, Medicare Part D, and New York Medicaid all potentially cover AndroGel, but prior authorization (PA) is nearly universal.

New York Medicaid

New York Medicaid covers AndroGel for male hypogonadism with prior authorization. The PA submission must document:

• Two morning total testosterone results below 300 ng/dL
• LH and FSH values confirming the hypogonadism type
• Documented symptoms consistent with hypogonadism
• Absence of active or recent prostate cancer
• PSA value below 4 ng/mL in men over 40

Your provider's office submits the PA through the eMedNY portal. Standard processing takes 3 to 5 business days; expedited review (for urgent cases) takes 24 to 72 hours. 12

Commercial Insurance PA Requirements

Blue Cross Blue Shield of New York, Empire BlueCross, United Healthcare, and Aetna all apply step-therapy requirements for testosterone gel under most plan designs. Step therapy typically means the plan requires a trial of one generic testosterone preparation before approving brand-name AndroGel. Documentation typically includes:

• Two lab results confirming low testosterone
• Provider attestation of symptom burden
• Clinical notes from the diagnosing visit
• Evidence of step therapy or clinical rationale for bypassing it

New York's 2016 Patients' Right to Know Act gives patients the right to request a step-therapy exception when generic therapy would be clinically inappropriate. 13

Denials can be appealed. The first level of appeal goes to the insurer's internal medical review team. If that appeal fails, New York patients may request an external appeal through the Department of Financial Services, which must be decided within 30 days (or 3 days for urgent matters). 14

Transferring an Existing AndroGel Prescription to New York

Patients relocating from another state face a specific regulatory question: can their current prescription follow them to New York?

New York does not honor out-of-state prescriptions for Schedule III controlled substances written by providers not licensed in New York. A prescription for testosterone gel written by a California physician cannot be filled at a New York pharmacy. 15

The practical solution is to establish care with a New York-licensed provider, which can be done via telehealth within the same week you relocate. Many platforms allow you to transfer your lab history so you do not need to repeat blood draws if your results are less than 90 days old and were drawn in the morning. Bring your previous prescription records, lab reports, and any prior authorization approvals from your former state to accelerate the new provider intake.

Applying AndroGel Correctly: Dosing and Transfer Risk

AndroGel 1.62% is applied once daily to the shoulders or upper arms. The starting dose is 40.5 mg (2 pump actuations or one 40.5 mg packet). Based on serum testosterone measured 14 days after starting, the dose may be adjusted to 20.25 mg (one pump), 60.75 mg (three pumps), or 81 mg (four pumps, the maximum). 1

Testosterone transfer to women, children, or adolescents through skin contact is the most clinically serious application error. The FDA has issued a black box warning specifically addressing this risk. Gel must dry completely (3 to 5 minutes) before clothing covers the application site, and users should wash hands immediately after application. Women and children should avoid direct contact with application sites; if contact occurs, they should wash the exposed area with soap and water as quickly as possible. 16

Serum testosterone should be measured 14 days after initiating therapy and again at 3 months, targeting mid-normal range (400 to 700 ng/dL) when drawn 2 to 8 hours after gel application. Hematocrit should be checked at 3 months and 6 months, then annually; values above 54 percent require dose reduction or temporary discontinuation. 4

Monitoring Schedule After Starting AndroGel

Consistent follow-up is not optional. New York providers and Endocrine Society guidelines both specify the following monitoring cadence after initiating testosterone gel therapy. 4

At 14 days. Total testosterone drawn 2 to 8 hours post-application. Dose adjustment based on this result.

At 3 months. Total testosterone, hematocrit, CBC, PSA (in men over 40), blood pressure, and symptom review.

At 6 months. Repeat hematocrit and PSA. Assess for any adverse effects including gynecomastia, edema, acne, or mood changes.

Annually. Full laboratory panel, bone mineral density (if baseline osteopenia was documented), and cardiovascular risk assessment.

The T-Trials reported no significant increase in cardiovascular events at 12 months in their study population, though they were not powered to assess rare events. 6 A 2023 randomized trial (TRAVERSE, N=5,246) found that testosterone replacement was non-inferior to placebo for major adverse cardiovascular events over a mean follow-up of 33 months (HR 0.96 to 95% CI 0.78 to 1.17). 17 That finding offers meaningful reassurance for men with pre-existing cardiovascular risk factors who previously avoided therapy.

Cost Comparison: Brand, Generic, and Compounded Testosterone Gel in New York

The table below presents a practical cost framework for New York patients choosing among their options. Prices reflect 2025 cash-pay estimates at New York pharmacies and do not account for insurance adjustments.

| Option | Monthly Cash Cost | Bioequivalence | Notes | |---|---|---|---| | AndroGel 1.62% brand | $400 to $600 | FDA-approved | AbbVie manufacturer coupons may reduce to $0 to $60 for commercially insured patients | | Generic testosterone 1.62% gel | $150 to $280 | FDA-approved AB-rated | GoodRx coupons may reduce to $40 to $90 | | 503A compounded testosterone gel | $30 to $80 | Not FDA-tested | Concentration customizable; no third-party bioequivalence data |

AbbVie's myAbbVie Assist program provides AndroGel at no cost to patients with household income at or below 400 percent of the federal poverty level who lack prescription coverage. 18

What Disqualifies a Patient From AndroGel in New York

Not every patient with low testosterone qualifies for AndroGel. Absolute contraindications under FDA labeling include:

• Known or suspected prostate carcinoma or breast cancer in men
• Women who are pregnant or may become pregnant (teratogenicity risk)
• Hypersensitivity to any component of the formulation

Relative contraindications requiring case-by-case evaluation include hematocrit above 50 percent, untreated obstructive sleep apnea, New York Heart Association Class III or IV heart failure, PSA above 4 ng/mL, and a strong family history of prostate cancer. 1

Men actively trying to conceive should discuss the fertility implications of testosterone therapy before starting. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, typically reducing sperm production to azoospermic or near-azoospermic levels within 3 months. 19 Human chorionic gonadotropin (hCG) co-therapy or selective estrogen receptor modulators such as clomiphene citrate are used off-label to preserve fertility during testosterone therapy, but they are distinct prescriptions that must be specifically requested and documented.

Frequently Asked Questions